Search Results - adedoyin+abraham

1 Results

Sort By:

Drugs That Reverse Epithelial-Mesenchymal Transition For The Treatment Of Metastatic Cancers

Epithelial-mesenchymal transition (EMT) is a driving force in tumor progression that transforms relatively benign epithelial tumor cells into mesenchymal or quasi-mesenchymal cells with cancer stem cell (CSC) properties, promoting the malignant phenotype that is highly drug resistant and metastatic. University of Colorado researchers have discovered...

Published: 11/30/2023 | Inventor(s): Daniel LaBarbera, Qiong Zhou, Adedoyin Abraham

Disease Areas Oncology

Category(s): Therapeutics